Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by elgin1on Jan 15, 2018 1:12pm

99 Views

Post# 27360226

RE:RE:RE:RE:JP Morgan Healthcare Conference

I agree more like licensing agreements with multiple companies. Sernova’s cell pouch will be instrumental for any stem cell company . They will have to cut a deal with Sernova . Once the pouch works and they sign their first commercial deal and it is proven to work ..... Time will tell. Let’s get the clinical trial going .

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features